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Scientifique, Cachan, FranceABSTRACT Cyclin-dependent kinases (CDKs) and their associated regulatory cyclins are central for timely regulation of cell-
cycle progression. They constitute attractive pharmacological targets for development of anticancer therapeutics, since they are
frequently deregulated in human cancers and contribute to sustained, uncontrolled tumor proliferation. Characterization of their
structural/dynamic features is essential to gain in-depth insight into structure-activity relationships. In addition, the identification
of druggable pockets or key intermediate conformations yields potential targets for the development of novel classes of inhib-
itors. Structural studies of CDK2/cyclin A have provided a wealth of information concerning monomeric/heterodimeric forms of
this kinase. There is, however, much less structural information for other CDK/cyclin complexes, including CDK4/cyclin D1,
which displays an alternative (open) position of the cyclin partner relative to CDK, contrasting with the closed CDK2/cyclin A
conformation. In this study, we carried out normal-mode analysis and enhanced sampling simulations with our recently devel-
oped method, molecular dynamics with excited normal modes, to understand the conformational equilibrium on these com-
plexes. Interestingly, the lowest-frequency normal mode computed for each complex described the transition between the
open and closed conformations. Exploration of these motions with an explicit-solvent representation using molecular dynamics
with excited normal modes confirmed that the closed conformation is the most stable for the CDK2/cyclin A complex, in agree-
ment with their experimentally available structures. On the other hand, we clearly show that an open4closed equilibrium may
exist in CDK4/cyclin D1, with closed conformations resembling that captured for CDK2/cyclin A. Such conformational prefer-
ences may result from the distinct distributions of frustrated contacts in each complex. Using the same approach, the putative
roles of the Thr160 phosphoryl group and the T-loop conformation were investigated. These results provide a dynamic view of
CDKs revealing intermediate conformations not yet characterized for CDK members other than CDK2, which will be useful for
the design of inhibitors targeting critical conformational transitions.INTRODUCTIONCyclin-dependent kinases (CDKs) are serine/threonine pro-
line-directed kinases, which are inactive in their monomeric
form but upon association to a family of regulatory subunits,
cyclins, form functional heterodimeric complexes (1,2). To
date, 20 different CDKs have been reported in mammalian
cells and about the same number of cyclins (3). Although
CDK1, CDK2, CDK4, and CDK6 are recognized regulators
of cell-cycle progression (4), other CDKs are implicated in
non-cell-cycle, unrelated biological pathways (5). Several
members of this family of kinases frequently have been
described as deregulated in human cancers (6). CDK/cyclins
are therefore now fully recognized as pharmacological
targets of interest for the development of anticancer thera-
peutics (7–9). Although CDKs are constantly expressedSubmitted March 2, 2015, and accepted for publication July 1, 2015.
*Correspondence: nicolas.floquet@univ-montp1.fr or david.perahia@
ens-cachan.fr
Nicolas Floquet and Mauricio G. S. Costa contributed equally to this work.
Editor: Ozlem Keskin.
 2015 by the Biophysical Society
0006-3495/15/09/1179/11throughout the cell cycle, their cyclin partners are periodi-
cally expressed and degraded according to specific spatio-
temporal patterns in healthy cells, thus dictating formation
and subsequent activation of their kinase partners in a
sequential and orderly fashion (1).
The general structure of CDKs is conserved throughout
the protein family, with a typical bilobal fold harboring a
conserved ATP-binding pocket within the N-terminal lobe.
The catalytic cleft of CDKs is located at the interface of
the two lobes. Likewise, cyclins are characterized by a
compact a-helix-rich cyclin fold, with variations in the
length and relative position of the helices. The nature of sur-
face residues can vary significantly in both CDKs and cy-
clins, further defining substrate and partner specificities
(10). Indeed, the cyclin partner directly contributes to sub-
strate recruitment through specific docking sites (11).
Activation of CDK/cyclin complexes is further subject to
several levels of control through reversible phosphorylations
as well as through interactions with structural inhibitors.
A first level of control occurs through phosphorylation ofhttp://dx.doi.org/10.1016/j.bpj.2015.07.003
1180 Floquet et al.residues that line the nucleotide-binding pocket, thus pre-
venting ATP binding (12). In contrast, phosphorylation
of the kinase T-loop by the CDK-activating kinase CAK
(on Thr160 for CDK2) contributes to CDK activation (13).
Many x-ray structures are available for the archetypal
CDK2, describing this kinase in its monomeric form or in
complex with its main partner, cyclin A.
The primary interaction between CDKs and cyclins in-
volves the conserved aC-helix (the PSTAIRE helix in
CDK2) and a-helix 5 of the cyclin (see Fig. 1) (14). Cyclin
binding to a CDK induces conformational changes in the
kinase subunit, as highlighted in the available crystal struc-
tures of CDK2/cyclin A and further evidenced through
mechanistic and kinetic studies (14,15). Specifically, com-
parison between the structures of monomeric CDK2 and
CDK2/cyclin A shows that cyclin binding induces a reorien-
tation of the ATP-binding pocket, leading to its alignment
with the catalytic cleft. Moreover, the presence of cyclin
A is associated with a conformational switch of the activa-
tion segment (or T-loop) of CDK2, thereby rendering the
substrate binding cleft more accessible and exposing this
loop for further phosphorylation. In this configuration, the
surface of interaction between the CDK2 and cyclin A is
important, and the heterodimeric complex can be considered
in a closed conformation (see Fig. 1). Phosphorylation
of CDK2 on Thr160 stabilizes the position of the T-loop,
thus favoring substrate binding, which ultimately leads to
an improved catalysis of the phosphotransfer reaction
(13,16,17).FIGURE 1 Representative closed (1JST) and open (2W9F, 3G33, 1G3N, and
complex, the kinase and cyclin subunits are reported in cyan and light gray, respec
tively. In the CDK2/cyclin A complex (PDB 1JST), the ATP and the phosphoryl
this study were performed on both the 1JST and 2W9F structures. To see this fi
Biophysical Journal 109(6) 1179–1189Other CDK/cyclin complexes are much less represented
in the Protein Data Bank (PDB). However, solved structures
for the CDK4/cyclin D1 (PDB 2W9F) (18), CDK4/cyclin
D3 (PDB 3G33) (19) and CDK6/cyclin K (PDB 1G3N)
(20) complexes reveal a different orientation of the cyclin
relative to the CDK, which will be termed as the open
conformation hereafter. This conformation is most often
associated with an inactive raised state of the T-loop (see
Fig. 1). The CDK9/cyclin T1 complex (PDB 3BLH) (21)
makes an exception, however, harboring the T-loop in an
active conformation but with the cyclin partner in the
open position (see Fig. 1). In this open conformation, the
interface between the CDK and the cyclin is essentially pro-
vided by the aC-helix. The rotation induced upon cyclin
binding is a critical step in CDK/cyclin activation, since it
aligns the ATP-binding pocket in the N-terminal lobe of
the CDK with the substrate binding cleft (14)
After structural alignment of the kinase fold of two repre-
sentative CDK/cyclin complexes, one in a closed and one in
an open conformation (CDK2/cyclin A and CDK4/cyclin
D1, respectively), the resulting root-mean-square deviation
(RMSD) computed on the cyclin partner is ~23 A˚, which
suggests that the two complexes have different modes of
regulation (18). In this study, we argued whether such a
large conformational rearrangement would be energetically
favorable and whether it is representative of all CDK/cyclin
complexes.
Normal mode analysis (NMA) is an efficient method for
identifying such large-amplitude motions that could hardly3BLH) structures of CDK/cyclin complexes available in the PDB. In each
tively. The aC-helix and the T-loop are highlighted in green and red, respec-
group on Thr160 are reported in colored sticks. Furthermore, calculations in
gure in color, go online.
Flexibility of CDK/Cyclin Complexes 1181be explored by classical molecular dynamics (MD) simula-
tions (22). From NMA, the eigenvectors corresponding to
the lowest frequencies are associated to the most collective
motions of the protein, and are generally involved in its
function (23). We have previously shown that although
normal modes (NMs) are calculated in vacuum, these direc-
tions can successfully describe conformational transitions in
proteins, showing remarkable agreement with structural ob-
servations (24–26). However, the major drawback of NMA
resides in the fact that it neglects the structural and energet-
ical effects of the surrounding water molecules, thus im-
pairing proper estimation of the amplitude of the modes.
Recently, we proposed MD with excited NMs (MDeNM)
(27) as an alternative method that uses the low-frequency
NMs computed in vacuum as privileged directions in MD
simulations with an explicit representation of the surround-
ing medium. In addition, we applied this method to simulate
large protein/protein complexes in a membrane model (28).
In this study, the NMs of the CDK2/cyclin A and CDK4/
cyclin D1 complexes were computed to identify the intrinsic
large-amplitude motions of CDK/cyclin complexes. After
identification of modes that successfully described the ex-
pected conformational transition, the MDeNM approach
was used to explore the equilibrium populations of con-
formers related to this motion in each complex, taking
into account the full aqueous environment.MATERIALS AND METHODS
Initial structures/models
In this study, two different x-ray structures available in the PDB were
considered: 1) the 1JST structure (17), describing the CDK2/cyclin A com-
plex, with a bound ATP, a phosphorylated Thr160, and an active T-loop
conformation; and 2) the 2W9F structure (18), corresponding to the
CDK4/cyclin D1 complex, with an inactive T-loop conformation (see
Fig. 1).
Calculations were also performed on the 1JST structure after removal of
the phosphorylation group on Thr160 (1JST_NOP), and on a 2W9F-based
model in which the activation loop was artificially introduced in an active
conformation by homology with 1JST (2W9F_HYBRID). The latter was
modeled using Modeler software (29). The best model according to the in-
ternal score of the software was selected among the 50 produced models for
further calculations. The entire homology modeling procedure was per-
formed considering the presence of the cyclin D1 partner.MD and NMA
Each starting structure (1JST, 1JST_NOP, 2W9F, and 2W9F_HYBRID)
was built using the CHARMM program (version 36) (30,31) with force-
field parameter set 27 and was inserted in a cubic box of TIP3 water
molecules, leaving at least 15 A˚ of water-shell thickness on all sides of
the protein/protein complex. Ions were added so that the global charge of
each system was neutralized. After a short energy minimization combining
steepest descent and adopted-basis Newton Raphson algorithms, a 500 ps
equilibration dynamics of the system was performed with CHARMM using
the Nose´-Hoover algorithm with the temperature fixed at 300 K (NVT con-
ditions) and an integration step of 1 fs. During these calculations, positional
restraints were applied only to the backbone atoms of the protein. Electro-static interactions were computed using a cutoff value of 12 A˚ and the par-
ticle-mesh Ewald method. The final equilibrated structure from the MD
simulations was considered for NMA. This structure was energy minimized
in vacuum using a cutoff value of 10 A˚ but with a switching function
applied between 10 and 12 A˚. A distance-dependent dielectric constant
of 2r was used, where r is the interatomic distance. After minimization in
vacuum, the 50 lowest-frequency NMs were computed using the DIMB
module of CHARMM (32).
The VMOD module as implemented in CHARMM was further used, as
we described previously, to generate energy-minimized conformations in
vacuum along the directions corresponding to each of the first 10 lowest-
frequency NMs. Briefly explained, this approach consists of displacements
along NM coordinates while performing energy minimizations, with har-
monic restraints at different windows. For more details, please refer to Flo-
quet et al. (24). In this study, a mass-weighted root mean-square (MRMS)
step of 0.2 A˚ was used to generate conformations in the range from 6 to
6 A˚ along each of the NM vectors considered. These models were used to
identify the mode(s) of interest, e.g., those that describe the transition be-
tween the open and closed conformations of CDK/cyclin complexes.Exploration of NMs with explicit representation of
the solvent
The mode(s) of interest corresponding to the open/closed conformational
transition were then used to performMDeNM simulations with explicit rep-
resentation of the solvent (27). The velocities of all the atoms of the system
were reread from the ending point of the 500 ps equilibration trajectory. Us-
ing the same force-field parameters, and without any applied restraint, 40
MDeNM replicas were performed for each simulated system. Each excita-
tion consists of assigning the considered NM as an incremental velocity
added to those obtained from the last frame of equilibration (for the first
excitation) or from the previous MDeNM simulation (for subsequent exci-
tations). These additional velocities define the excitation temperature that is
added to the current temperature promoting a motion along the positive or
negative direction along the mode.
Because of the rapid dissipation of this excitation energy due to atomic
motions along other degrees of freedom and to the constant temperature al-
gorithm, the MDeNM simulations were performed under periodic excita-
tions (in this case, five). Each replica corresponds to a random value of
the excitation temperature and a random direction for the excitation (posi-
tive or negative) along the mode. After this step, 4000 conformers (40
replicas  5 excitations  20 ps) obtained for each system were grouped,
and the Carma software (33) was used to compute a Ca-Ca RMSD matrix
of the concatenated trajectory so obtained. This full set of conformations
was then reduced to its 20 most representative members using the k-means
algorithm implemented in the R software (www.r-project.org). After the
clustering procedure, an additional 2 ns of unrestrained MD simulations
was carried out starting from each of the 20 clusters, using NAMD (34)
and the same force-field parameters that were used with CHARMM. This
conformational exploration step yielded a final 40 ns concatenated trajec-
tory. All resulting conformations of this trajectory were projected on the
chosen NM vector for further amplitude/population analyses. The projec-
tions correspond to the scalar product between the atomic displacement
vector (the difference between the displaced conformation and the initial
conformation from which the NMs were computed) and the NM vector.
Since the NM vector is a mass-weighted unit vector, the atomic displace-
ment vector was mass weighted before the projection. Thus, each compo-
nent of the displacement vector was multiplied by
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
mi=M
p
(24). For a
pure displacement vector (which coincides with the NM vector), the square
of the projection corresponds to the MRMS difference between the dis-
placed and the initial structures. Thus, for a given structural displacement
arising from an MD simulation, the real MRMS values with respect to
the initial structure (referred to here as the RMSD) are larger than the
MRMS values obtained by the projections onto the NM vector (see
Fig. 3). The protocol used in this study is summarized in Fig. 2.Biophysical Journal 109(6) 1179–1189
FIGURE 2 Summary of the protocol used in this
study for the CDK2/cyclin A (1JST), CDK4/cyclin
D1 (2W9F), 1JST_NOP, and 2W9F_HYBRID
complexes. To see this figure in color, go online.
1182 Floquet et al.Analysis of experimental structural variations
Experimental conformations were obtained using ProDy v.1.5.1 (35). First,
a blast search against the PDB database was performed to retrieve structures
sharing at least 70% sequence identity with the reference complex (CDK2/
cyclin A or CDK4/cyclin D1). Then, the obtained ensembles were superim-
posed using the Kabsch algorithm as described in Bakan and Bahar (36).
Only Ca atoms were considered in these calculations. A principal-compo-
nent analysis (PCA) was then performed to identify the most relevant struc-
tural variations of the experimental data set. A list of the PDB IDs of this
experimental data set is provided in the Supporting Material. The PCA pro-
cedure is based on the diagonalization of the covariance matrix, c, of atomic
positions whose elements are represented by
cði;jÞ ¼

Dri$Drj

;
where Dri and Drj indicate the displacement vectors of atoms i and j,
respectively, from their average positions. Brackets stand for ensembleaverages. Then, an eigenvalue problem is solved, resulting in 3N PCs,
which can be sorted according to their fractional contributions to the overall
variance.Dynamical cross-correlation analysis
Correlation coefficients between pairs of residues were calculated from the
covariance matrix of atomic positions (c(i,j)) considering only the positions
of Ca atoms. The cross-correlation matrices, C (normalized covariance),
were calculated according to the equation
Cði;jÞ ¼

Dri$Drj

hDr2i i1=2$

Dr2j
1=2:
In the above equation, fully correlated motions have a value of þ1 and
completely anticorrelated motions have a value of 1. This analysis was
intended to identify correlated regions within a given protein. Calculations
were conducted with R software using the Bio3D package (37).Local frustration analysis
All energetic frustration analyses were conducted with the Frustratometer
web server (38). Calculations were performed considering CDK/cyclin
complexes in both open and closed states. The CDK-2/cyclin A open state
and CDK-4/cyclin D1 closed state were obtained upon 4 A˚ displacements
along their corresponding lowest-frequency modes. Briefly, the program
calculates the energetic frustration of each contact on the structure submit-
ted by the user in comparison to a set of generated decoy states where theBiophysical Journal 109(6) 1179–1189identities of each residue are mutated. A contact is defined as minimally
frustrated or highly frustrated by comparing its frustration energy with
the values obtained from the decoy states, as further described in Ferreiro
et al. (39).RESULTS
The lowest-frequency mode of CDK/cyclin
complexes describes an open/closed
conformational transition
After preparation and energy minimizations (with
CHARMM) of the two CDK2/cyclin A (PDB 1JST, closed
conformation) and CDK4/cyclin D1 (PDB 2W9F, open
conformation) complexes, their 50 lowest-frequency NMs
were computed. Subsequently, the VMOD subroutine was
applied to generate 61 energy-minimized conformations
along each of the first 10 lowest-frequency NMs for each
complex. In both cases, the lowest-frequency motion ac-
counted for ~40–50% of the overall dynamics, whereas
the cumulative contribution of the first five modes was
>85% (Fig. S1 in the Supporting Material). Fig. 3 shows
the RMSD values computed for all intermediate models
against the expected open and closed positions, respectively,
of their cyclin. To that purpose, each displaced complex
along the mode considered was first rotated by RMS struc-
tural fitting of the CDK part onto its corresponding target
followed by structural fitting of the cyclin part (i.e., dis-
placed structures of CDK2/cyclin A compared to the target
x-ray structure of CDK4/cyclin D1, and vice versa, dis-
placed structures of CDK4/cyclin D1 compared to the target
x-ray structure of CDK2/cyclin A). The reported RMSD
values are those between the cyclins. The reference
RMSD value computed between the open and closed con-
formations of the CDK/cyclin complexes was ~23 A˚. For
each complex, a linear decrease/increase of RMSD values
was observed along mode 7, confirming the importance of
this mode in the description of the conformational transition
between the open and closed positions of the CDK/cyclin
complex. In contrast, minor contributions were observed
FIGURE 3 RMSD values computed considering
the cyclin conformation on the displaced complex
along the five lowest-frequency modes and its
position in the x-ray target complex after super-
imposing the respective CDK proteins, as ex-
plained in the text. (A) Displaced CDK2/cyclin A
complex and target CDK4/cyclin D1 complex.
(B) Displaced CDK4/cyclin D1 complex and target
CDK2/cyclin A complex. The MRMS values in the
abscissa correspond to the displacements along the
modes considered. A MRMS value of 0 corre-
sponds to the initial energy-minimized model
used for NM calculations. For purposes of clarity,
only the results obtained for the five lowest-fre-
quency NMs of each complex were reported. To
see this figure in color, go online.
Flexibility of CDK/Cyclin Complexes 1183regarding the subsequent modes (modes 8–11). Moreover,
the identification of such intrinsic motion in both complexes
strongly suggested the occurrence in solution of relevant,
but not yet revealed, conformational states along the mode
7 direction. These states may vary between more open con-
formations for the CDK2/cyclin A complex and more closed
conformations for the CDK4/cyclin D1 than those reported
in the related crystallographic structures. Fig. 3 also shows
that a very large-amplitude motion, e.g., with an MRMS
value >6 A˚ along mode 7, was required to decrease the
global RMSD between the cyclins to a value <7 A˚. Indeed,
pushing the normal coordinate for the seventh mode further,
the linearity of the RMSD variation was lost and reached a
plateau before arriving at a nonzero-RMSD structure.The closed CDK2/cyclin A complex remains
closed in water
Using the MDeNM technique (27), we first explored the
accessible conformations in explicit solvent obtained upon
excitation of mode 7 computed for the CDK2/cyclin A com-
plex. This technique allows coupling between fast and slow
motions without the introduction of biases or restraints.
Briefly, incremental velocities (DvNM) along the NM direc-
tions are added to current velocities obtained after an equil-
ibration MD simulation. This incremental kinetic energy
along specific degrees of freedom corresponds to the excita-
tion of one or more low-frequency modes related to large-
amplitude motions that are hardly explored during standard
MD simulations. Therefore, with multiple short replica
MDeNM simulations, large conformational changes are
enhanced and the definition of the maximum extent of sam-
pling by mode is solely based on intrinsic features of the
system.
Inspection of the MDeNM trajectories revealed that
the expected closed/open transition motion was properly
explored, even using a moderately low value of incrementaltemperature (DTnm¼ 5 K). The large-amplitude motion pro-
moted led to a decrease of the RMSD between closed and
open states from 23 to 4.2 A˚ (Fig. S2 A). In addition, we
noticed the occurrence of more closed conformations, re-
sulting in a marked increase of contact area between
CDK2 and cyclin A. The contributions of other modes to
the structural transition are not significant, as shown by pro-
jections of the concatenated MDeNM trajectory onto them
(Fig. S3). To clarify these results, we refer to Movie S1,
which shows the sampled conformers in water for CDK2/
cyclin A, together with an animation showing the transition
between the initial conformation (the equilibrated x-ray
structure) and the conformation sharing the lowest RMSD
to the open conformation (Fig. S4).
After concatenation of the MDeNM trajectories and clus-
tering of the conformations obtained (using the k-means
method), additional 2 ns MD simulations were performed
starting from the central conformations (centroids) obtained
on each of the 20 resulting clusters. These simulations were
required to dissipate the kinetic perturbations previously
introduced and to reach a population of conformers in ther-
modynamic equilibrium (27). Fig. 4 A displays the projec-
tions of the resulting conformations onto the mode 7
coordinate (blue line). The narrow peak centered on 0 A˚
MRMS indicates a small extent of sampling, and therefore,
most of the sampled conformations remained close to the
initial structure. Nevertheless, the small peak observed
at 2 A˚ MRMS indicates that open conformations were
explored, but to a lesser extent. On the other hand,
completely closed conformations (previously suggested by
the initial VMOD results in vacuum) were not observed.
These results were in striking agreement with the projec-
tions of a set of 98 experimental x-ray structures describing
the CDK2/cyclin A complex (Fig. 4 A, black line). Similar
results were obtained after a 25 ns standard MD simulation
performed in water (Fig. 4 A, red line), although in this
case no open conformations were obtained. Interestingly, aBiophysical Journal 109(6) 1179–1189
FIGURE 4 (A) Results of population analysis based on projections of the conformations obtained for the CDK2/cyclin A complex after MD resampling of
the 20 clusters resulting fromMDeNM simulations along mode 7 (blue), after a screening of the PDB (98 structures) (black), and after a 25 ns MD simulation
of the starting PDB 1JST structure (red). (B and C) Residue-residue cross-correlation analyses were performed through PCA of the MDeNM data (25 qua-
simodes) (B) or the collected 98 x-ray structures (C). The CDK-2 and cyclin A structural domains are highlighted in the margins of each cross-correlation
map. The matrices in (B) and (C) show no significant discrepancies, sharing a Mantel test (40) value of 0.8. To see this figure in color, go online.
1184 Floquet et al.comparison of the correlation coefficients between pairs of
residues (cross correlations) obtained after PCA of the coor-
dinates obtained from 1) MDeNM simulations (Fig. 4 B) or
2) the x-ray data subset (Fig. 4 C) confirmed that our
MDeNM simulations successfully described the intrinsic
collective motions that could be guessed from all available
x-ray structures.
To confirm the visual analysis, we performed a Mantel
test (40) using R, which yielded a high correlation value
(0.8), thus indicating that both cross-correlation maps are
indeed similar. Further, a lower correlation value (0.68)
was obtained when comparing standard MD and experi-
mental data. This analysis indicates that MDeNM simula-
tions better capture the intrinsic structural variation of the
CDK-2/cyclin A complex. Altogether, these results show
that the CDK2/cyclin A complex clearly prefers a closed
conformation in solution. The same protocol was performed
on the CDK2/cyclin A complex after removal of the phos-
phoryl group on Thr160, but the results were not significantly
altered. Among other observations, it was verified that the
removal of the phosphoryl group did not affect the overall
flexibility of the protein/protein complex or, more specif-
ically, of the activation loop (see Fig. S5).The open CDK4/cyclin D1 complex can adopt a
closed conformation in water
The same protocol was performed on the CDK4/cyclin D1
complex. Results from the MDeNM simulations are re-
ported in Fig. S2 B. Again, the opening/closing motion
along mode 7 was properly explored during our simula-
tions using a maximum of 5 K excitation, leading to a
closed conformation sharing a low 4.4 A˚ RMSD value
against the expected position of the cyclin, and closely
related to that observed in the CDK2/cyclin A structureBiophysical Journal 109(6) 1179–1189(See Fig. S6). From the analysis of the projections onto
the other low-frequency modes, it seems that only mode
9 had a small contribution to closure motions (projections
reaching 51.5 A˚) (Fig. S3). Interestingly, more open
conformations were also explored for this complex. The
conformations sampled during MDeNM simulations are
reported in Movie S2. After clustering of the excited trajec-
tories and resampling of representative conformations dur-
ing MD simulations along this motion, we obtained the
equilibrium populations (Fig. 5, blue line). As compared
to CDK2/cyclin A, larger conformational changes were
observed for this complex, with significant sampling of
closed conformations at 4 A˚ MRMS. Open conformations
beyond the crystallographic structure were also observed.
Although for CDK4 the amount of x-ray data is limited,
our results suggest that a closed conformation of the
CDK4/cyclin D1 complex, closely related to that captured
experimentally for the CDK2/cyclin A, could be generated.
Similar results were obtained starting from the CDK4/cy-
clin D3 complex, suggesting a common feature that does
not depend on the cyclin partner (data not shown). The
equilibrium populations obtained from a standard MD
simulation (Fig. 5, red line) showed limited sampling
along the opening/closing motion, reinforcing the impor-
tance of MDeNM in the exploration of large structural
transitions.Conformational propensities on CDK/cyclin
complexes are related to their distinct networks of
frustrated contacts
We asked whether the distinct conformational propensities
observed in the MDeNM simulations of CDK/cyclin com-
plexes could be associated with their distinct networks
of contacts. In this context, we performed a frustration
FIGURE 5 Results of population analysis based on projections of the
conformations obtained for the CDK4/cyclin D1 complex after MD resam-
pling of the 20 clusters resulting from MDeNM simulations along mode 7
(blue) and after a 25 ns MD simulation of the starting PDB 2W9F structure
(red). To see this figure in color, go online.
Flexibility of CDK/Cyclin Complexes 1185analysis (39) on both complexes considering their open
and closed forms. Briefly, this analysis allows one to
determine how localized sequence and conformational
perturbations influence energetic frustrations, measuringFIGURE 6 Localizing and evaluating frustration in CDK/cyclin complexes. M
respectively. (A and B) Visualization of the frustration networks for the less-frust
contacts upon structural transition from an open to a closed conformation ðDNc ¼
top part of each plot. To see this figure in color, go online.how favorable a particular contact is relative to other
possible local interactions. Comparing the closed and
open conformations of each complex, the number of
highly frustrated contacts is higher in the CDK-2/cyclin
A open state. In contrast, the CDK-4/cyclin D1 closed
state is more frustrated. The decrease of highly frustrated
interactions per residue (Fig. 6, C and D, red) when going
from an open to a closed state (negative values) in CDK2/
cyclin A, but not in CDK4/cyclin D1, corroborates the
increased propensity of the former to remain in a closed
state, whereas the latter is more stable in an open state.
The opposite trend observed regarding the number of
minimally frustrated contacts reinforces this observation
(Fig. 6, C and D). Fig. 6, A and B, display how the local
energetic frustration is distributed over the less-frustrated
state of each CDK/cyclin complex. It is interesting to note
that they correspond to their available crystallographic
structures.
However, it is noticeable that even the most favorable
state of each complex displays localized frustrations, as
shown in Fig. 6, A and B. Both networks show that individ-
ual domains are connected by several minimally frustrated
contacts, whereas highly frustrated regions are mostly
localized at the interface. As previously mentioned (39),
these frustrated contacts are associated with regions prone
to undergoing conformational changes, which also corrobo-
rates the occurrence of large-amplitude motions in these
complexes.inimally and highly frustrated contacts are represented in green and red,
rated state of each complex. (C and D) Variation of the number of frustrated
Nclosedc  Nopenc Þ. The domain definitions of each complex are given in the
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closing motion of CDK/cyclin complexes
In the starting structure of the CDK4/cyclin D1 complex
(PDB 2W9F), the T-loop is found in an inactive conforma-
tion (see Fig. 1). To investigate the putative role of this loop
conformation in the open/closed equilibrium, we built a
hybrid model based on the starting structure but with the
T-loop changed to an active conformation (as observed
in the CDK2/cyclin A complex). After equilibration of
this model with CHARMM, the computed mode 7 again
described the open/closed transition, presenting a contribu-
tion to the overall fluctuations similar to that observed for
the original CDK-4/cyclin D1 complex (Fig. S1). Analysis
of MDeNM simulations yielded similar results to those
observed for the inactive loop complex, showing a greater
flexibility of the cyclin than was displayed by the CDK2/cy-
clin A complex (data not shown). After clustering and re-
sampling of intermediate conformations, as performed for
the other complexes, the thermodynamic equilibrium popu-
lations reported in Fig. 7 were obtained. Compared to the
2W9F complex, we observed both open and closed states
in similar proportions, a clear modification of the profile
previously obtained with simulations starting with an inac-
tive loop conformation.Dynamical cross-correlation analyses of CDK2/
cyclin A and CDK4/cyclin D1 complexes
The comparison between the dynamical correlation patterns
observed in the complexes revealed some important differ-
ences. Fig. 8 shows the cross correlations calculated after
MD sampling from excited clustered structures. The corre-FIGURE 7 Equilibrium population distribution obtained after projec-
tions onto mode 7 of the conformations explored by MD after MDeNM
simulations of the HYBRID model. To see this figure in color, go online.
Biophysical Journal 109(6) 1179–1189sponding two-dimensional maps are given in Figs. 4 B
(CDK2/cyclin A) and S7 (CDK-4/cyclin D1 and the hybrid
model). In both complexes, positive correlations were
observed within the C-terminal portions of both CDK and
cyclin. However, the N-terminal domains of both CDK4
and cyclin D1 presented stronger correlations than did those
of the CDK2/cyclin A complex (Figs. 4 B and S7). The dif-
ferences in the anticorrelation patterns were striking.
Whereas in the CDK2 /cyclin A complex the anticorrela-
tions were noticed only between a small part of the C-lobe
and the C-terminal of cyclin A, in CDK4/cyclin D1, both
intra- and intermolecular anti-correlations were observed.
This finding interestingly demonstrated that the opening/
closing motion that was much more explored in the
CDK4/cyclin D1 complex was coupled to an intrinsic dy-
namics of the kinase, moving its two lobes toward opposite
directions. The PSTAIRE helix at the interface of the two
proteins clearly plays a key role in the mechanical transmis-
sion. Interestingly, when the T-loop conformation was
switched (hybrid complex), both inter- and intramolecular
anticorrelations were weakened, resulting in an intermediate
profile between CDK4 (2W9F) and CDK2 complexes,
definitively demonstrating the role of this motion in the
transmission of mechanical information between the cyclin
and kinase partners.DISCUSSION
In this study, we explored the large-amplitude motions
occurring in two CDK/cyclin complexes, 1) CDK2/cyclin
A, whose x-ray structure corresponds to a closed state of
the heterodimeric complex, and 2) CDK4/cyclin D1, which
has been elucidated in an open state. The closed and open
states are defined by the relative position of the cyclin
with respect to the CDK subunit. In both cases, the
lowest-frequency NM described the conformational transi-
tion between the closed and open states, suggesting that
such motion is an intrinsic propensity of both CDK/cyclin
complexes.
As calculations were performed in vacuum, they did not
account for solvent effects, which ultimately impair a proper
estimation of amplitudes of motion and the populations
of the different conformational states in thermodynamic
equilibrium at 300 K. To gain further insight into these
issues, the lowest-frequency mode calculated for each of
the complexes was assigned as a privileged direction in
MDeNM simulations, where collective motions are kineti-
cally excited within MD simulations. The MDeNM simula-
tions allowed us to generate a large set of intermediate
excited structures along the transition pathway described
by the lowest mode in either of the two complexes studied.
The results clearly showed that such motion is energetically
feasible in both complexes.
Further, from the projections of the trajectories onto mode
7, we noticed energetically accessible conformations along
FIGURE 8 Dynamical cross correlations (C(i,j))
plotted onto the structures of CDK/cyclin com-
plexes CDK2/cyclin A (A) and CDK4/cyclin D1
(B). The red and blue edges connect pairs of resi-
dues that are correlated or anticorrelated, respec-
tively. Darker edges indicate stronger couplings,
as reported in the color scale. The most important
domains were highlighted and the arrows in the
margins of the structures indicate the main direc-
tions of large-amplitude motions observed during
the trajectories. To see this figure in color, go
online.
Flexibility of CDK/Cyclin Complexes 1187this collective coordinate beyond those found in the crystal
structures. To obtain populations of structures in thermody-
namic equilibrium, a set of unrestrained MD simulations
was carried out starting from representative structures
retrieved after a clustering procedure on the MDeNM trajec-
tories. For the CDK2/cyclin A complex, we observed that
most of the sampled conformations were predominantly
closed, therefore resembling the distribution obtained from
a set of 98 crystallographic structures. In contrast, CDK4/
cyclin D1 presented a much greater conformational plas-
ticity, with both closed and open states markedly populated,
although the crystal structure of this complex only reveals
the existence of an open conformation. This feature was in
agreement with the higher tendency of this complex to be
refractory to structure determination.
We also identified the distinct networks of frustrated con-
tacts in full accordance with the structural and dynamic data,
since the CDK-2/cyclin A open state and the CDK-4/cyclin
D1 closed state are more frustrated, being probably less
stable in solution.
It is important to emphasize the importance of such
hybrid calculations combining NMA and MD on the evalu-
ation of dynamical features of complexes in a complete
aqueous environment. Standard MD used alone usually fails
to properly account for such large conformational changes,
especially when opening/closing mechanisms are involved.
Although NMA yields propensities for such transitions, the
equilibrium populations only can be disclosed when the
large-amplitude motions are evaluated in the context of a
dynamical simulation (27).
From the conformational equilibrium, several dynam-
ical properties can be obtained and compared to experi-
mental data with significant agreement, as shown here
(see Fig. 4), as well as for other systems (27). In some appli-
cations, MDeNM was shown to perform better than other
well-established enhanced sampling methods such as meta-
dynamics or umbrella sampling (27,41–46).
We also propose an important role of the T-loop confor-
mation on the equilibrium between open and closed states.
Nevertheless, modifying only its conformation was not
sufficient to fully switch the intrinsic dynamical profileof CDK4/cyclin D1 to that observed for CDK2/cyclin A.
The effect of loop conformations within the overall dy-
namics on proteins or complexes is of general interest.
We recently showed the importance of the catalytic loop
conformation in the context of opening/closing events tak-
ing place on the glutamate decarboxylase protein (47). We
anticipate that this conformational flexibility may enable
such complexes to adapt their conformation upon interac-
tion with other partners, or may occur and be prompted
upon substrate binding to achieve optimal phosphoryl
transfer reaction. It has indeed been suggested that the
interaction of CDK4/cyclin D substrate, p107Rb, may
bring CDK4 and cyclin D closer together so as to promote
the conformational changes necessary to bring the CDK4
T-loop into an active conformation (18,19). Our results
reveal that this conformational change is indeed energeti-
cally possible and permitted to generate conformational
ensembles that will now be useful for the design of drugs
targeting the CDK/cyclin interface (see Fig. S8). These
studies are also in line with the fact that CDK4, being a
central portal for integration of cell growth and inhibition
signals to stimulate exit from quiescence and entry into the
cycle of cell growth and division, may also bind to other
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